Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values  J. Turnidge, G. Kahlmeter,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
Gut bacterial microbiota and obesity
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
An eye-catching acanthocephalan
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
Surveillance of Legionnaires’ disease in Austria
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
D.E. Low  Clinical Microbiology and Infection 
Vector control: a cornerstone in the malaria elimination campaign
Pharmacodynamics of doxycycline
Training for the infectious diseases speciality in Norway
E.C. Böttger  Clinical Microbiology and Infection 
Cephalosporins: a pharmacological update
Retrospective study of CMV retinitis in patients with AIDS
Epidemiology of opportunistic infections in AIDS patients
D. Esel, B. Sümerkan, S. Kocagöz  Clinical Microbiology and Infection 
G. Kronvall  Clinical Microbiology and Infection 
Elements of design: the knowledge on which we build
S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter 
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
Levofloxacin in the treatment of ventilator-associated pneumonia
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Metagenomics and probiotics
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
A case of pleurisy associated with antibodies to Rickettsia conorii
Pathogenesis of catheter-related infections: lessons for new designs
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.
M.B. Kerrn, N. Frimodt-Møller, F. Espersen 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species  G. Kronvall, E. Holst  Clinical Microbiology.
Real-time comparative monitoring of the A/H1N1 pandemic in France
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Modelling during an emergency: the 2009 H1N1 influenza pandemic
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
European recommendations for antimicrobial resistance surveillance
J.L. Balcázar  Clinical Microbiology and Infection 
G. Kahlmeter  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
S.-H. Kung, S.-F. Wang, C.-W. Huang, C.-C. Hsu, H.-F. Liu, J.-Y. Yang 
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values  J. Turnidge, G. Kahlmeter, G. Kronvall  Clinical Microbiology and Infection  Volume 12, Issue 5, Pages 418-425 (May 2006) DOI: 10.1111/j.1469-0691.2006.01377.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Interative procedure for analysing increasing subsets of pooled data: benzylpenicillin and Streptococcus pneumoniae showing a visual demonstration of analysing increasing subsets of pooled data; results of the analyses are presented in Table 1. Data are presented as a frequency distribution, although analyses were performed on cumulative frequency distributions, as illustrated in the more detailed examples in Fig. S1 (see Supplementary material). The procedure involved fitting the initial subset and generating estimates for the number of strains in the subset, the mean and the standard deviation (in log). This procedure was repeated by adding to the previous subset each successive column to create the next subset, and repeating the curve-fitting until it was clear that there was a subset where the absolute difference between the estimated and true number of strains was a minimum. In this example, the five subsets examined showed that the subset ‘MIC = 0.03 mg/L’ gave the minimum difference. Clinical Microbiology and Infection 2006 12, 418-425DOI: (10.1111/j.1469-0691.2006.01377.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions